 |
View a brief presentation by Jennifer Moniz Carpenter, MBA, in which she discusses opportunities and obstacles to success in the autism spectrum disorder drug market. Ms. Moniz Carpenter is the author of the Spectrum report entitled The Autism Spectrum Disorders Market: Substantial Opportunity and Unique Challenges.
  |
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Amy H. Whiting, Ph.D., in which she discusses the drug treatment market for Asthma. Dr. Whiting is the author of the Pharmacor Asthma report.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Madhuri Borde, Ph.D., in which she discusses treatment trends in hypertension. Dr. Borde is the author of the Treatment Algorithms in Hypertension report.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Bethany A. Kiernan, Ph.D., in which she discusses the drug treatment market for multiple sclerosis. Dr. Kiernan is the author of the Pharmacor Multiple Sclerosis report.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Amanda Puffer, M.Sc., in which she discusses treatment trends in multiple sclerosis (MS). Ms. Puffer is the author of the Treatment Algorithms is Multiple Sclerosis report.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Neil Grubert, M.A.,in which he discusses the outlook for pharmaceutical pricing and reimbursement in major markets. Mr. Grubert is the author of the Spectrum report entitled Strategic Overview of Pricing and Reimbursement in the Major Markets.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Lisa Arias in which she discusses treatment trends in the hospital setting for osteomyelitis. Ms. Arias is the author of the Hospital Anti-Infectives Insight Series: Osteomyelitis report.
View a brief presentation by Lisa Arias in which she discusses treatment trends in the hospital setting for nosocomial pneumonia. Ms. Arias is the author of the Hospital Anti-Infectives Insight Series: Nosocomial Pneumonia report.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Jing Wu, M.S., MBA, in which she discusses the growing market for breast cancer therapies in India. Ms. Wu is the author of the Emerging Markets report entitled Breast Cancer in India.
|
| ........................... |
.....................................................................................................................
|
 |
View a brief presentation by analyst Sandra Chow in which she discusses the bipolar depression drug market. Ms. Chow is the author of the recent Pharmacor Bipolar Depression report.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Nicole Westphal, Ph.D., in which she discusses treatment trends in asthma. Dr. Westphal is the author of the Treatment Algorithms in Asthma report.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Michael Malecki, Ph.D., in which he discusses barriers to drug treatment, lines of therapy and forecast of events by lines of therapy in chronic obstructive pulmonary disease (COPD). Dr. Malecki is the author of the Treatment Algorithms in Chronic Obstructive Pulmonary Disease report.
|
| ........................... |
..................................................................................................................... |
.aspx) |
View a brief presentation by analyst Irene Koulinska, M.D., in which she discusses the cell therapies market. Dr. Koulinska is the author of the Industry Report entitled Cellular Therapies.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by Jose L. Avalos, Ph.D., in which he discusses the drug treatment market for HIV. Dr. Avalos is the author of the Pharmacor Human Immunodeficiency Virus report.
View a brief presentation by analyst Jose Avalos, Ph.D., in which he discusses the drug treatment market for severe fungal infections. Dr. Avalos is the author of the Pharmacor report entitled Severe Fungal Infections.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by analyst Jonathan Searles in which he discusses the drug treatment market for attention-deficit/hyperactivity disorder. Mr. Searles is the author of the Pharmacor report entitled Attention-Deficit/Hyperactivity Disorder.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by analyst Carlos Dedesma, Ph.D., in which he discusses the changing marketplace for Tysabri in light of recent events. Dr. Dedesma is a research analyst on the Pharmaview team at Decision Resources.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by analyst Sylivia Eash, Ph.D., in which she discusses the HIV drug treatment market. Dr. Eash is the author of the Pharmacor report entitled Human Immunodeficiency Virus which finds that the market for HIV therapies will experience robust 5.4 percent annual growth through 2012.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by analyst Sami Fam, Ph.D., in which he discusses the drug treatment market for Parkinson's disease. Dr. Fam is the author of the Pharmacor report entitled Parkinson's Disease which finds that the generic erosion of market leading therapies will constrain the Parkinson's disease drug market.
|
| ........................... |
..................................................................................................................... |
 |
View a brief presentation by analyst Nathan Calloway in which he discusses the drug treatment market for generalized anxiety disorder. Mr. Calloway is the author of the Treatment Algorithms in Generalized Anxiety Disorder report which finds that Lexapro is the leading single agent used in anxiety therapy.
|